-
A Comparative Analysis of Similarities and Differences of RWE Standards Across Regulatory and Health Technology Assessment Bodies
Sep 9, 2025, 16:22 PM -
Rising Costs in Pharmaceutical Services: A Decade of Prescription Spending Trends in Türkiye 2015-2024
Sep 9, 2025, 16:22 PM -
Analysis of Historical European Medicines Agency (EMA) Marketing Authorization (MA) Timelines: Will EU Joint Clinical Assessment (JCA) Timelines Be Longer Than Expected?
Sep 9, 2025, 16:22 PM -
Productivity Costs Due to Respiratory Infections in Denmark: A Potential for Prophylaxis
Sep 9, 2025, 16:22 PM -
Can Adalimumab Serve as Big Mac Index for Pharmaceutical Prices?
Sep 9, 2025, 16:22 PM -
Developing Best Practice for Using Automation Tools in Literature Reviews
Sep 9, 2025, 16:22 PM -
Impact of Comparator Type on Cost-Effectiveness Outcomes: Insights From ASMR III Evaluations in France
Sep 9, 2025, 16:22 PM -
Evaluating the Economic Value of First-Line (1L) Treatment Strategies for Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC): Insights From the Portuguese Healthcare System
Sep 9, 2025, 16:22 PM -
The PAVING II Interview Study: Assessing Evolving Patient Preferences Regarding Gene Therapy for Hemophilia Patients
Sep 9, 2025, 16:22 PM -
Agentic-AI Analyzer to Chat With Your Excel-Based Cost-Effectiveness Models
Sep 9, 2025, 16:22 PM -
Integrating Mendelian Randomization With Real-World Evidence: Cost-Effectiveness of Lipoprotein Testing for Primary Prevention of Cardiovascular Disease in High-Income Countries
Sep 9, 2025, 16:22 PM -
Fezolinetant Veoza™ As a Nonhormonal Treatment for Moderate to Severe Vasomotor Symptoms in Postmenopausal Women: A Systematic Literature Review and Meta-Analysis
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Implementing Spirometry Screening for COPD in Primary Care in Russia
Sep 9, 2025, 16:22 PM -
Importance of Adjudication Committees in Retrospective Chart Review Studies for Outcomes Event Data Collection
Sep 9, 2025, 16:22 PM -
Health Economic Evaluation Model for Prostate Cancer Risk Management Through Preimplantation Genetic Testing for Monogenic Disorders (PGT-M)
Sep 9, 2025, 16:22 PM -
The Societal Value of Lecanemab for Patients With Early Alzheimer's Disease in Japan
Sep 9, 2025, 16:22 PM -
Dealing With Missing Data in Health Economic Studies of Small to Moderate Size: How to Minimize Bias
Sep 9, 2025, 16:22 PM -
Comparative Prevalence of Suicidal Ideation and Self-Harm History: Rexulti vs. Other Oral Atypical Antipsychotics
Sep 9, 2025, 16:22 PM -
Economic and Antibiotic Benefits of Vonoprazan-Based Regimens for First-Line Helicobacter Pylori Eradication in China
Sep 9, 2025, 16:22 PM -
From Clinic to Cohort: The VOICE Vitiligo Registry and Bioresource as a Blueprint for High-Fidelity Specialist Registries
Sep 9, 2025, 16:22 PM
